- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06520046
Motor Control Prevention Strategies in Basketball Players
Motor Control Prevention Strategies for Ankle Sprains in Basketball Players
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rocío Llamas-Ramos, PhD
- Phone Number: 657854188
- Email: rociollamas@usal.es
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Basketball players aged between 10-18 years old who play regularly in one of the basketball clubs in the city of Salamanca.
Exclusion Criteria:
- previous injuries
- fractures
- use of orthoses and technical aids
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motor control group
Basketball players aged between 10-18 years old who play regularly in one of the basketball sports clubs in the city of Salamanca. The study will be carried out in 20 sessions. As for the proprioception and balance work, a simple proposal of exercises will be made, increasing the difficulty from the fifth session onwards. From the 10th session onwards, unstable surfaces will be introduced as long as our athletes are capable of achieving the task of less complexity. If it is not possible to progress in intensity, the same level will be maintained. |
Propioceptive exercises
|
|
Active Comparator: Control
Basketball players aged between 10-18 years old who play regularly in one of the basketball sports clubs in the city of Salamanca. These participants shall carry out their usual treatment |
Usual exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of motion
Time Frame: At the beginning and at 9 months
|
Measurements of the articular range of the ankle joint
|
At the beginning and at 9 months
|
|
Musculature Strength
Time Frame: At the beginning and at 9 months
|
Measurement of the strength of the musculature of the back of the leg by means of isokinetic tests
|
At the beginning and at 9 months
|
|
Presence of Myofascial trigger points
Time Frame: At the beginning and at 9 months
|
Diagnostic criteria established by Travell and Simons, the presence or absence of active or latent myofascial trigger points will be assessed.
|
At the beginning and at 9 months
|
|
Speed of contraction of the musculature
Time Frame: At the beginning and at 9 months
|
By means of the isokinetic tests and the aforementioned exploratory curves, the speed of contraction of the musculature of the back of the leg and foot will be evaluated
|
At the beginning and at 9 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MOTORCONTROL2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.